Christopher C. Lemasters, EVP, Chief Business Officer at Mirati Therapeutics, Inc. (MRTX), sold 120,000 shares at $71.65 ($8.6M) on 2019-02-14, disclosed to the SEC on 2019-02-19.
Open-market sale of $8.6M MRTX by EVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.65 | 41,438 | $3.0M | 34.5% |
| 2 | $71.65 | 41,438 | $3.0M | 34.5% |
| 3 | $72.06 | 18,562 | $1.3M | 15.5% |
| 4 | $72.06 | 18,562 | $1.3M | 15.5% |
| Total | $71.78 avg | 120,000 | $8.6M | 100% |